rtmark
LearnBonds.com

High Hopes in Cannabis Sector: ZeaKal Raise $15 Million Series C Funding

Biotech company ZeaKal has gone public revealing that it has settled on a Series C financing round which offers high hopes for hemp. The San-Dieo biotech startup company mainly focuses on improving genetic crop traits photosynthesis rates through neatly tweaking them.

The Series C financing round is worth $15 million. However, it includes $10 million strategic investment from Canopy Rivers as announced in the beginning of the year. Also, the round has its two main investors as Middleland Capital and Finistere Ventures.

Improving the Photosynthesis Rates

ZeaKal targets improving the crops photosynthesis rates due to two primary reasons. First, the photosynthesis rates of the modern crops still falls below the genetic potential. Also, there is still unnoticeable efforts on how plants can increase their effectiveness in creating energy despite individuals optimizing the way plants store the energy.

With such situations, ZeaKal seeks to improve the photosynthesis rates of genetic and modern crops using PhotoSeed. PhotoSeed refers to the next generation technology trait which is responsible for increasing photosynthesis rates at sustainable extent. Also, it is responsible for improving the compositional quality of the crops in their seeds.

ZeaKal PhotoSeed is effective in the cannabis sector for it will initiate the production of more yields, as much as twice. More so, ZeaKal PhotoSeed will act as a simple solution particually for complex solution in the cannabis sector. Affirming this, Mary Dimou who is the business development director at Canopy Rivers states that the ZeaKal PhotoSeed will be able to solve the very low hanging problems that the cannabis sector has been encountering for the last 80 years. As a result, ZeaKal PhotoSeed will help both cannabis and hemp gradually and quickly evolve to an extent of being produced legal and for long.

Parting Shot

Indeed, ZeaKal raising $15 million Series C Funding is a great hope to and in the cannabis sector, especially through its PhotoSeed technology. The technology will not only solve the low hanging problems that the cannabis sector has been encountering for eight decades, but also help the evolution of both hemps and cannabis in the near future.

Trusted & Regulated Stock & CFD Brokers

What we like

  • 0% Fees on Stocks
  • 5000+ Stocks, ETFs and other Markets
  • Accepts Paypal Deposits

Min Deposit

$200

Charge per Trade

Zero Commission

Rating

64 traders signed up today

Visit Now

75% of investors lose money when trading CFDs.

Available Assets

  • Total Number of Stocks & Shares5000+
  • US Stocks
  • German Stocks
  • UK Stocks
  • European
  • ETF Stocks
  • IPO
  • Funds
  • Bonds
  • Options
  • Futures
  • CFDs
  • Crypto

Charge per Trade

  • FTSE 100 Zero Commission
  • NASDAQ Zero Commission
  • DAX Zero Commission
  • Facebook Zero Commission
  • Alphabet Zero Commission
  • Tesla Zero Commission
  • Apple Zero Commission
  • Microsoft Zero Commission

Deposit Method

  • Wire Transfer
  • Credit Cards
  • Bank Account
  • Paypall
  • Skrill
  • Neteller

What we like

  • Sign up today and get $5 free
  • Fractals Available
  • Paypal Available

Min Deposit

$0

Charge per Trade

$1 to $9 PCM

Rating

Visit Now

Investing in financial markets carries risk, you have the potential to lose your total investment.

Available Assets

  • Total Number of Shares999
  • US Stocks
  • German Stocks
  • UK Stocks
  • European Stocks
  • EFTs
  • IPOs
  • Funds
  • Bonds
  • Options
  • Futures
  • CFDs
  • Crypto

Charge per Trade

  • FTSE 100 $1 - $9 per month
  • NASDAQ $1 - $9 per month
  • DAX $1 - $9 per month
  • Facebook $1 - $9 per month
  • Alphabet $1 - $9 per month
  • Telsa $1 - $9 per month
  • Apple $1 - $9 per month
  • Microsoft $1 - $9 per month

Deposit Method

  • Wire Transfer
  • Credit Cards
  • Bank Account
All trading carries risk. Views expressed are those of the writers only. Past performance is no guarantee of future results. The opinions expressed in this Site do not constitute investment advice and independent financial advice should be sought where appropriate. This website is free for you to use but we may receive commission from the companies we feature on this site.
Justinas Baltrusaitis

Justin is an editor, writer, and a downhill fan. He spent many years writing about finances, blockchain, and crypto-related news. He strives to serve the untold stories for the readers.